United States · Series B startup

Who invested in Ollin Biosciences

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$430Mraised across 2 rounds since 2025, from 2 sources

$100MSeries A$330MSeries B
Latest round
Series B, $330MJun 2026
Step-upi
3.3×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026
$100MSeries A$330MSeries B
First round
Series A, $100M
Sept 2025
Biggest round
$330M
Series B · Jun 2026
Between rounds
9 months
from the last two

The rounds

  1. Jun 2026
    Series B$330M3 new2 returning

    Source recordedSEC filing: $156M sold

  2. Sept 2025
    Series A$100M2 new

    Source recorded

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

ARCH Venture PartnersVC firm2rounds
MubadalaPrivate equity2rounds
RA Capital ManagementPrivate equity1round
TCGPrivate equity1round
TCG CrossoverVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Ollin Biosciences

Who invested in Ollin Biosciences?

Ollin Biosciences's investors include ARCH Venture Partners, Mubadala, RA Capital Management, TCG and TCG Crossover.

How much has Ollin Biosciences raised?

Ollin Biosciences has raised $430M across 2 rounds since 2025.

When did Ollin Biosciences last raise?

Ollin Biosciences's most recent round was a Series B of $330M in Jun 2026.

What was Ollin Biosciences's biggest round?

Its most recent round, $330M in Jun 2026, is also its largest on record.

Who backed Ollin Biosciences first?

Ollin Biosciences's first round on record, in Sept 2025, was backed by ARCH Venture Partners and Mubadala.

What stage is Ollin Biosciences at?

Ollin Biosciences's latest named round is a Series B, in Jun 2026.

Where is Ollin Biosciences based?

Ollin Biosciences is based in the United States.

Companies like Ollin Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.